Treatment(s) already received-Radical prostatectomy - Page 3 of 6 Posts on Medivizor
Navigation Menu

Treatment(s) already received-Radical prostatectomy Posts on Medivizor

Radium 223-dichloride as a treatment for castration resistant prostate cancer

Radium 223-dichloride as a treatment for castration resistant prostate cancer

Posted by on Apr 3, 2017 in Prostate cancer | 0 comments

In a nutshell This study investigated how effective and safe radium 223 dichloride treatment was in patients with castration resistant prostate cancer (CRPC). It was concluded that radium 223 dichloride increased overall survival, reduced symptomatic skeletal events risk and was safe.  Some background Treatment to decrease the male hormones,...

Read More

Looking for overweight or obese prostate cancer patients with disease progression after primary therapy

Looking for overweight or obese prostate cancer patients with disease progression after primary therapy

Posted by on Feb 6, 2017 in Prostate cancer | 0 comments

In a nutshell This phase 2 trial aims to evaluate the benefit of adding metformin (Glucophage) to hormone therapy with bicalutamide (Casodex). The main outcome to be investigated is treatment response. The trial is recruiting in Philadelphia (Pennsylvania), USA. The details Obesity and metabolic syndrome (a collection of conditions including...

Read More

Can radiation and hormone therapy after surgery improve prostate cancer survival rates?

Can radiation and hormone therapy after surgery improve prostate cancer survival rates?

Posted by on Jan 21, 2017 in Prostate cancer | 1 comment

In a nutshell The aim of this study was to determine whether radiation therapy in combination with hormonal therapy improved survival in men with prostate cancer that has spread to the lymph nodes after surgery. Researchers concluded that patients treated with radiation therapy and hormone therapy had a significantly higher survival rate compared to...

Read More

Examining surgery as a primary treatment for high-risk prostate cancer

Examining surgery as a primary treatment for high-risk prostate cancer

Posted by on Dec 12, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined evidence for the role of prostate surgery in treating high-risk prostate cancer. Authors concluded that surgery is an effective primary treatment option for men with high-risk disease. Some background Localized prostate cancer is cancer that is confined to the prostate gland. Men with high-risk localized prostate...

Read More

Surgery as a treatment for an infected pubic bone in prostate cancer survivors

Surgery as a treatment for an infected pubic bone in prostate cancer survivors

Posted by on Nov 21, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the effectiveness of pubic bone removal on pain intensity associated with an infected pubic bone in prostate cancer survivors. Authors concluded that surgical treatment is an effective approach in providing long-term pain relief from an infected pubic bone. Some background Surgery and radiation are two first-line...

Read More

Two new predictors of cancer recurrence after surgery: Perineural invasion and lymphovascular invasion

Two new predictors of cancer recurrence after surgery: Perineural invasion and lymphovascular invasion

Posted by on Aug 13, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined two new predictors of prostate cancer recurrence – perineural invasion (PNI) and lymphovascular invasion (LVI). Researchers reported increased recurrence risk after prostate surgery if patients show PNI or LVI before surgery, particularly if both were present.  Some background Localized (confined)...

Read More

Examining the risk of disease recurrence more than 10 years after prostate surgery

Examining the risk of disease recurrence more than 10 years after prostate surgery

Posted by on Jul 29, 2016 in Prostate cancer | 2 comments

In a nutshell This study examined risk factors for prostate cancer recurrence more than 10 years after prostate surgery. Researchers concluded that disease recurrence rates continued to increase between 10 and 20 years after surgery. Age at surgery and increased cancer markers were found to be predictive of late disease recurrence. Some background...

Read More